🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the efficacy, safety, tolerability...
Status
Completed
Location
Study site
Start Date
2010-09
Trial ID
NCT01199705
Treatments Being Tested
This multicenter, open-label, parallel-arm, non-randomized study is designe...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-02-01
Trial ID
NCT03033745
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study site
Start Date
2007-09
Trial ID
NCT00542997
Treatments Being Tested
This is a prospective, phase 3, multicenter, double-blind, randomized place...
Status
Terminated
Location
University of Alabama Hospital at Birmingham
Start Date
2024-08-28
Trial ID
NCT06524739
This study is a continuation of the study ZLB06\_001CR with the objective o...
Status
Completed
Location
Study Site
Start Date
2008-08
Trial ID
NCT00751621
Treatments Being Tested
The objective of this study is to assess the long-term safety, tolerability...
Status
Completed
Location
Study site
Start Date
2011-04
Trial ID
NCT01458171
Treatments Being Tested
The pHeNIx study, a national multicentre prospective non-interventional stu...
Status
Recruiting
Location
CHU Amiens Picardie 1
Start Date
2022-06-10
Trial ID
NCT04672733
Treatments Being Tested
This is an open-label, multicenter, phase 4 study in IG treatment-naïve par...
Status
Completed
Location
Research Solutions of AZ
Start Date
2025-07-15
Trial ID
NCT07076446
Treatments Being Tested
The objective of this study is to assess the efficacy, tolerability, safety...
Status
Completed
Location
Study Site
Start Date
2006-11
Trial ID
NCT00419341
Treatments Being Tested
This is a phase 3, multicenter, randomized, placebo-controlled, double-blin...
Status
Terminated
Location
8401117 - Arizona Arthritis & Rheumatology Research
Start Date
2019-10-21
Trial ID
NCT04044690
Treatments Being Tested